. Increased palmitoyl-myristoyl-phosphatidylcholine in neonatal rat surfactant is lung specific and correlates with oral myristic acid supply. J Appl Physiol 111: 449 -457, 2011. First published June 2, 2011 doi:10.1152/japplphysiol.00766.2010.-Surfactant predominantly comprises phosphatidylcholine (PC) species, together with phosphatidylglycerols, phosphatidylinositols, neutral lipids, and surfactant proteins-A to -D. Together, dipalmitoyl-PC (PC16:0/16:0), palmitoyl-myristoyl-PC (PC16:0/14:0), and palmitoylpalmitoleoyl-PC (PC16:0/16:1) make up 75-80% of mammalian surfactant PC, the proportions of which vary during development and in chronic lung diseases. PC16:0/14:0, which exerts specific effects on macrophage differentiation in vitro, increases in surfactant during alveolarization (at the expense of PC16:0/16:0), a prenatal event in humans but postnatal in rats. The mechanisms responsible and the significance of this reversible increase are, however, not understood. We hypothesized that, in rats, myristic acid (C14:0) enriched milk is key to lung-specific PC16:0/14:0 increases in surfactant. We found that surfactant PC16:0/14:0 in suckling rats correlates with C14:0 concentration in plasma chylomicrons and lung tissue triglycerides, and that PC16:0/14:0 fractions reflect exogenous C14:0 supply. Significantly, C14:0 was increased neither in plasma PC, nor in liver triglycerides, free fatty acids, or PC. Lauric acid was also abundant in triglycerides, but was not incorporated into surfactant PC. Comparing a C14:0-rich milk diet with a C14:0-poor carbohydrate diet revealed increased C14:0 and decreased C16:0 in plasma and lung triglycerides, respectively. PC16:0/14:0 enrichment at the expense of PC16: 0/16:0 did not impair surfactant surface tension function. However, the PC profile of the alveolar macrophages from the milk-fed animals changed from PC16:0/16:0 rich to PC16:0/14:0 rich. This was accompanied by reduced reactive oxygen species production. We propose that nutritional supply with C14:0 and its lung-specific enrichment may contribute to decreased reactive oxygen species production during alveolarization. lung development; dipalmitoyl phosphatidylcholine; lipoproteins; myristic acid; neutral lipids LUNGS ARE STABILIZED BY surfactant, a complex containing ϳ80 -85% phospholipids, 10% neutral lipids, and 5-10% proteins, including the surfactant proteins (SP)-A to -D. The molecular composition of surfactant varies according to differences in pulmonary physiology, anatomy, and development (29). This variability is described not only for its proteins, but also for its major phospholipids (2, 3, 28) .
(PC16:0/16:0) (29, 41) . However, mammalian surfactant also contains significant amounts of disaturated palmitoyl-myristoylphosphatidylcholine (PC16:0/14:0) and monounsaturated palmitoyl-palmitoleoyl-phosphatidylcholine (PC16:0/16:1), which are preferentially secreted by type II pneumocytes (PN-II) (3) . PC16: 0/14:0, for example, ranges from 8 -12% in human surfactant to 25% in some mammals, in contrast to avian lungs, in which it is virtually absent (2, 21) . PC16:0/14:0 increases during alveolarization, which takes place in utero in humans and guinea pigs, but occurs postnatally in the rat and mouse (3, 29) . In vitro PC16:0/ 14:0 mimics the effects of natural surfactant on macrophage (M⌽) differentiation and M⌽-dependent inhibition of T-lymphocyte proliferation (17) , suggesting an important regulatory role in alveolar M⌽ functions.
While maternal glucocorticoid treatment administered to trigger fetal PN-II differentiation in premature babies does not alter surfactant phosphatidylcholine (PC) composition (1, 16) , maternal lipoprotein loading stimulates fetal surfactant synthesis (33) . In keeping with this, triglyceride (TG) stores are increased postnatally in rat lungs (25, 40) , suggesting that lipid supply to the lungs may be important for surfactant maturation. Our laboratory recently investigated the impact of nutrition on surfactant PC composition using synthetic TGs, together with stable isotope labeled fatty acids, where we showed that the PC16:0/14:0 concentration was dramatically increased by trimyristin (C14:0 3 ), and to a lesser extent by trilaurin (C12: 0 3 ), due to lung-specific accumulation of exogenous myristic acid (C14:0) and elongation of lauric acid (C12:0) to C14:0 (27) . As rat milk is rich in C12:0 and C14:0, we hypothesized that increased PC16:0/14:0 in postnatal rat surfactant may strongly depend on the physiological variation of these fatty acids. We, therefore, investigated the link between C12:0 and C14:0 supply via rat milk nutrition and the induced changes in surfactant phospholipidomics. Furthermore, we analyzed the lipid fractions of plasma and liver, to further support our hypothesis that C14:0 enrichment in surfactant PC is lung specific, and that such enrichment is variable during normal development. Reasoning that the specific enrichment of myristoylated surfactant PC during mammalian development (5, 28) may play a functional role, we determined the effects of the induced surfactant PC profile changes on surface tension function in vitro. We further investigated the impact of PC16:0/ 14:0 enrichment of surfactant on PC metabolism and homeostasis of alveolar M⌽ in vivo and on their function in terms of the production of reactive oxygen species (ROS). Our results suggest that physiological variations in dietary C14:0 increased PC16:0/14:0 in surfactant at the expense of PC16:0/16:0. This lung-specific effect involves chylomicrons and is limited to C14:0 incorporation, whereas C12:0, also abundant in rat milk, is excluded from incorporation into surfactant PC. Whereas surface tension function of surfactant in vitro, ventilation rate, and animal growth were unchanged, production of ROS by alveolar M⌽ was decreased in cells exposed to high PC16:0/ 14:0 surfactant. We speculate that the surfactant-specific increase in PC16:0/14:0, resulting from the increased C14:0 supply during alveolarization, helps protect against radicalinduced impairment during development.
MATERIALS AND METHODS
Phospholipid and fatty acid standards were from Sigma-Aldrich (Deisenhofen, Germany) or Avanti Polar Lipids (Alabaster, AL). Chloroform and methanol [high-performance liquid chromatography (HPLC) grade] were from Baker (Deventer, The Netherlands), whereas n-butanol (analytic grade) was from Merck (Darmstadt, Germany). RPMI medium was from Biochrom (Berlin, Germany), whereas fetal calf serum and phorbol 12-myristate-13-acetate from Sigma-Aldrich (Munich, Germany). Other chemicals (analytical grade) were from various commercial sources.
Animal maintenance. Sprague-Dawley rats were kept specific pathogen free and had ad libitum access to carbohydrate-rich standard diet (Provivmi Kliba SA3336, 5.5% fat) and tap water. Spontaneously delivered pups of either sex were removed from their mothers directly before death at postnatal days (d) 1-2 or d14 -15, or at d21 to investigate adult rats. To compare milk (rich in C14:0 and C12:0) with standard diet, animals were either kept with their mothers with no access to standard diet or removed at d19 and fed Provivmi Kliba SA3336 until death at d24; d19 was chosen to ensure animals were mature enough to feed themselves on standard diet. Animal growth was monitored, and gastric content analyzed at death. Experiments were approved by the local government and met the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. For the investigation of PC metabolism of M⌽, rats with surfactant naturally rich in PC16:0/14:0 (d14) or poor in PC16:0/14:0 and rich in PC16:0/16:0 (adult) were injected with 50 mg/kg [D 9 methyl]choline chloride intraperitoneally 1.5 h before death, based on the finding that it takes ϳ1.5 h before labeled PC is actively secreted, whereas incorporation of [D9-methyl]choline into cell PC starts immediately (4, 27) .
Harvesting of samples. Rats were killed by intraperitoneal injection of 100 mg ketamine and 20 mg xylazine (WDT, Garbsen, Germany) per kilogram body weight. Blood (0.2-3 ml) was collected into ethylenediaminetetraacetic acid-coated containers by puncturing the right heart ventricle and centrifuged at 1,000 g for 10 min, and the plasma supernatant was harvested. Lungs were perfused with ice-cold 0.9% saline to remove blood and lavaged to harvest 4 -32 ml (depending on age) lung lavage fluid (LLF/surfactant), and LLF cells were separated by centrifugation (200 g, 10 min, 4°C) (3). After decantation of the cell-free supernatant, cell pellets (Ͼ98% M⌽) of rats exposed in vivo to a surfactant rich in PC16:0/14:0 (d14) or a surfactant poor in PC16:0/14:0 (adult) were washed twice extensively with excess isotonic phosphate-buffered saline without calcium and magnesium (PBS) (14 ml, 4°C). Cells were then resuspended in 2.2 ml PBS, containing 5.6 mmol/l glucose. For mass spectrometric analysis of phospholipids, 0.2-ml aliquots were extracted according to Bligh and Dyer (6), whereas 2 ml were immediately subjected to experiments for the generation of ROS and FACS analysis. Lungs and livers were excised, and gastric contents gently squeezed out. Samples were snap frozen in liquid nitrogen and stored at Ϫ80°C until analysis.
Lipoprotein preparation. Plasma (0.75 ml) was placed in 5-ml polyethylene tubes, mixed with 0.75-ml 64% (wt/vol) NaBr solution (density: 1.308 g/ml), and sequentially overlaid with 1.5 ml 16% NaBr (1.135 g/ml) and 1.5 ml distilled water (density: 1 g/ml) (11). Samples were centrifuged at 200,000 g for 2.5 h in a model AH-650 rotor using a Discovery SE ultracentrifuge (Sorvall, Newton, CT). The layer on top of the distilled water was regarded as chylomicrons (density Ͻ0.95 g/ml), whereas material from top of the 16% NaBr downwards was regarded as nonchylomicron lipids. Fractions were aspirated with 1-ml syringes and immediately extracted.
Lipid analysis. Lipids were extracted from LLF, blood plasma, lipoproteins, and LLF cells (6) , as well as from lung, liver, and gastric contents (14) . Their phospholipid content was measured as previously described (3), with the exception of the LLF cells due to the minimal phospholipid amounts obtained. For PC and TG isolation (2, 5, 27) , material containing 0.5-1.0 mol phospholipid was dried down, dissolved in 1 ml chloroform, applied to 100 mg Strata NH2 cartridges (Phenomenex); and TG and PC were sequentially eluted with 3 ϫ 1 ml chloroform and 1.2 ml chloroform-methanol (2 ϩ 1 vol/vol), respectively. Fatty acids from chymus lipids, TG, and PC were analyzed using gas chromatography after transformation to fatty acid methyl esters using 13,16,19-docosatrienoic as an internal standard (22) , a HP5890 gas chromatograph (Hewlett Packard) equipped with a flame ionization detector (250°C), hydrogen/synthetic air as combustion gases, and a 60 m ϫ 0.25 mm Rtx2330 column (Restek) with helium as carrier gas. Column settings were 80°C for 2 min, then 30°C/min increase to 120°C, and 2°C/min increase to 240°C. Quantification was performed using calibration curves for the respective components. Analysis of PC species of all organs, LLF, and plasma was performed with HPLC, as described previously (26) .
Mass spectrometric analysis of PC in cells of LLF. Lipid extracted M⌽ suspensions were concentrated under nitrogen and resuspended in butanol-methanol-water (75:23:2 vol/vol/vol). Composition of endogenous and [D 9 -methyl]choline labeled PC species was determined by electrospray ionization tandem mass spectrometry in the positive ionization mode using a Thermo-Finnigan TSQ Quantum Discovery Max (Thermo-Fisher Scientific, Dreieich, Germany), as previously described (27) . Quantification of endogenous PC and [methyl-D9]-labeled PC was performed in the selected reaction monitoring mode by monitoring transitions from the parent ions of the major PC molecular species (Table 1) , which, together, comprise at least 95% of total PC to the diagnostic fragments mass-to-charge ratio (m/z) ϭ ϩ184 (phosphocholine) and m/z ϭ ϩ193 (D9-labeled phosphocholine) for the endogenous and newly synthesized PC species, respectively.
Water-soluble PC precursors. Choline and phosphocholine were quantified in the water/methanol phase of plasma and lung tissue extracts using D4-choline as an internal standard. Components were separated using an HPLC model 1100 (Agilent, Waldbronn, FRG), an Atlantis HILIC silica column (2.1 ϫ 30.0 mm) (Waters, MA) at 50°C, and a gradient elution of 500 mM ammonium formate (pH 4.1) and acetonitrile/0.05% formic acid (4). Metabolites were quantified on a Micromass Quattro Micro triple-quadrupole (Waters, Eschborn, Germany) under positive ionization, with multiple-reaction monitoring employing the following transitions: choline ϭ 103.8
Analysis of surfactant function. Surfactant function was assessed with a pulsating bubble surfactometer (PBS, Electronetics, Amherst, NY), as described previously (2, 28) . LLF was centrifuged at 40,000 g for 15 min at 4°C to sediment large aggregates, and the pellets were adjusted with 154 mM NaCl/1.5 mM CaCl2 to give phospholipid concentrations of 3 mg/ml. A sample aliquot was instilled into the chamber of the PBS; a bubble created in the sample and surfactant allowed adsorption to the interface for 10 s. The bubble was then pulsated at a rate of 20/min. The pressure across the bubble was followed for 100 pulsations, and minimum surface tension was calculated using the Laplace equation.
Quantification of ROS. LLF cells were counted in an ultraplane Neubauer hemocytometer, adjusted to 1 ϫ 10 5 cells/ml in RPMI with 5% fetal calf serum, and placed in a 24-well plate. ROS production was quantified according to Rothe and Valet (32) . In brief, cells were incubated with dihydrorhodamine (Sigma, Munich, Germany, 1 mol/l) for 5 min at 37°C, followed by induction of ROS production by phorbol 12-myristate 13-acetate (Sigma, 100 nmol/l). After 30 min, cells were placed on ice, stained with phycoerythrin-labeled monoclonal antibody anti-rat-CD45 (BD Biosciences, Heidelberg, Germany) for 15 min, washed with PBS, and immediately analyzed on a FACS Scan cytometer (BD Biosciences). Cells were gated by forward vs. side scatter and CD45 expression. Mean dihydrorhodamine-fluorescence intensities were assessed. Unstimulated cells served as control.
Statistics. Data are expressed as means Ϯ SE. Differences were tested by a two-tailed Student's t-test, or by one-way analysis of variance for multiple-group comparisons using Graph Pad Instat 3 (Graph Pad Software, San Diego, CA). Multiple-group comparisons were corrected using the method of Bonferroni-Holm. P values of Ͻ0.05 were regarded as significant.
RESULTS
Fatty acids of lung and plasma TG relative to postnatal surfactant PC. The reversible increase of PC16:0/14:0 in LLF and lung tissue at d14 compared with term and d42, which occurred at the expense of PC16:0/16:0 (Fig. 1, A and C) , was accompanied by a concurrent increase in C14:0 and C12:0 of lung tissue and blood plasma TG (Fig. 1, B and D) . Other PC species in LLF or lung tissue did not follow this pattern, either continuously decreasing or increasing with age, or maintaining their d14 concentrations. At d14, when PC16:0/14:0 in LLF was doubled relative to term and d42 values, both C14:0 and C12:0 were increased severalfold in lung and plasma TG (P Ͻ 0.001). These reversible increases were mostly at the expense of oleic acid (C18:1) (Fig. 1, B and D) . However, changes in C18:1 and palmitic acid (C16:0) were not followed by the equivalent changes of palmitoyloleoyl-PC or PC16:0/16:0 in lung tissue or surfactant (Fig. 1, A-D) .
Dietary effects on animal growth and overall lipid and fatty acid homeostasis. Fatty acid composition of gastric contents of d14 rats fed on milk, and of d24 rats fed on milk vs. rodent chow, are given in Table 2 . Data show that, compared with chow, rat milk comprised 9 -17% C14:0 and 18 -22% C12:0, which was mainly at the expense of C16:0, C18:1, and linoleic acid (C18:2). By contrast, chow contained Ͻ2% of C12:0 and C14:0. Animal weight, breathing rate, liver weight, and weight of gastric contents were unaffected by dietary interventions from d19 -24, while the gastric lipid content of milk-fed animals was fivefold higher for milk than for chow-fed animals. Withdrawal of milk feeding at d19 resulted in decreased liver and plasma phospholipids. However, lung tissue phospholipids were unchanged, whereas those in LLF were slightly increased. Diet did not influence the pool sizes of PC precursors, choline, and phosphocholine in lung tissue. Similarly, the plasma concentrations of choline were unchanged (Table 3 ). In Monoisotopic masses of individual lyso-phosphatidylcholine (PC) and PC species were calculated, and masses analyzed by parent scan of lipid extracts, using endogenous [mass-to-charge ratio (m/z) ϭ ϩ184], D3-(m/z ϭ ϩ187), D6-(m/z ϭ ϩ190), and D9-choline phosphate (m/z ϭ 193) as diagnostic fragments, as described elsewhere (4, 27) . For routine analysis, the endogenous and deuteriated PC components comprising Ͼ95% of PC were analyzed in the specific reaction monitoring mode after loop injection, as described in MATE-RIALS AND METHODS. both lung and liver, TG pools and their concentrations relative to phospholipid were decreased in chow controls, whereas differences in plasma were not significant (Table 4) .
In plasma and lung tissue TG of milk-fed animals, C14:0 and C12:0 were increased severalfold over standard chow (Fig. 2, A  and C) , where, after 5d, values had dropped to near zero in plasma (P Ͻ 0.001) and by 30 -50% in lung tissue (P Ͻ 0.01). Accordingly, C14:0 withdrawal decreased C14:0 in lung tissue PC from 6.9 Ϯ 0.6 to 2.6 Ϯ 0.3% and in LLF from 11.6 Ϯ 0.3 to 6.3 Ϯ 0.8%. The decrease of C14:0 in PC increased the fraction of C16:0 and palmitoleic acid (Fig. 2, B and D) . Interestingly, irrespective of its concentrations in TG (Fig. 2, A and C) , C12:0 was virtually absent from lung tissue and surfactant PC (Fig. 2, B  and D) .
Effects of milk diet on surfactant PC molecular species composition and surfactant function. Diet-induced changes in C14:0 concentrations of lung and surfactant PC are reflected by corresponding changes of the intact PC species. While continuous milk feeding resulted in pulmonary PC profiles identical to those expected for d14 animals, 5d milk/C14:0 withdrawal reduced PC16:0/14:0 significantly, while PC16:0/16:0 was increased, i.e., composition was directed toward that of adult rat surfactant (Fig. 1, A and C, Fig. 3, A and B) .
We investigated the potential physiological role of such lipidomic changes by measuring surfactant surface tension and alveolar M⌽ function. In vitro, surface tension function was only minimally altered (Fig. 3C) . However, the basal production of ROS of freshly isolated alveolar M⌽ from 14d milk-fed rats, naturally exposed to a surfactant rich in PC16:0/14:0 (for comparison, see Fig. 1A ), was reduced by 50 -65% compared with M⌽ from adult rats, exposed to a surfactant low in PC16:0/14:0. Furthermore, phorbol 12-myristate-13-acetate did not stimulate ROS production in the PC16:0/14:0-enriched d14 rat alveolar M⌽ at all (Fig. 4A) . Addressing PC metabolism and composition of these cells (Fig. 4, B and C) by [D 9 -methyl]choline labeling and electrospray ionization tandem mass spectrometry showed that both d14 and adult M⌽ Values are means Ϯ SE; N, no. of rats. Rats were either fed on mother's milk until death at postnatal day (d) 24 or removed from their mothers at d19 and fed on rodent chow until death at d24. Fatty acid composition (mol%) of total lipids from gastric contents was determined. For comparison, fatty acid composition of d14 gastric contents is shown. * P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. milk fed, d24. Values are means Ϯ SE; N, no. of rats. Rats fed on mother's milk throughout or on rodent chow from d19 onwards were killed at d24. LLF, lung lavage fluid. *P Ͻ 0.05; **P Ͻ 0.01. Values are means Ϯ SE of 3-11 experiments. Rats were either milk fed from d1 until death at d24, or removed from their mothers at d19 and fed on rodent chow for 5 days until sacrifice. Triglycerides of lavaged lung tissue, liver, and blood plasma were analyzed and expressed relative to total phospholipid pools as mol triglyceride fatty acids. Values in parentheses are percentage changes relative to controls (ϭ100%). P values were calculated according to two-sided t-test, as described in MATERIALS AND METHODS. **P Ͻ 0.01; ***P Ͻ 0.001. primarily synthesized PC species containing arachidonic acid, together with components containing C18:1 and C18:2 ( -methyl]choline-labeled surfactant PC is already secreted into the alveoli, data not shown), the molecular composition of newly synthesized PC in the isolated M⌽ had approximated the surfactantlike composition of whole nonlabeled M⌽-PC (P Ͼ 0.05) (Fig.  4, B and C, wide striped bars) .
Lung specificity of C14:0 incorporation into PC. Analysis of plasma fractions from 14d suckling rats showed that C14:0 and C12:0 were highly enriched in the chylomicron fraction (Fig. 5A ). Neither liver TG or PC (Fig. 5, B and C) , nor total plasma PC (not shown) comprised significant amounts of C14:0 or PC16: 0/14:0, nor were their concentrations increased by C14:0/milk diet. However, there was a direct correlation between total plasma C14:0 and lung surfactant PC16:0/14:0, which inversely correlated PC16:0/16:0 (P Ͻ 0.001). No such correlation was found for C16:0 supply (Fig. 6) . rats. Rats were either fed on mother's milk from birth until death at d24 or were removed from their mothers at d19 and fed chow for 5 days before death (d19 -d24). Values are means Ϯ SE of 5 vs. 3 (plasma TG), 9 vs. 11 (lung TG), 6 vs. 6 (lung PC), and 9 vs. 11 (LLF PC) experiments, respectively. C22:6, docosahexaenoic acid. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. Fig. 3 . Composition of lung tissue (A) and surfactant (LLF; B) PC and surfactant function in vitro (C) of d24 rats receiving mother's milk from birth until death (d24) or removed from their mothers at d19 and fed chow for 5 days (d19-d24). Values are means Ϯ SE of 9 vs. 11 experiments. ␥min, Minimal surface tension; ns, nonsignificant. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001; ****P Ͻ 0.0001. during development, while PC16:0/14:0 is decreased in chronic lung diseases (3, 29) . In contrast, hormonal stimulation induces parallel increases (1, 16) , whereas the PC synthesis pattern of human fetal lung explants is defined by incubation conditions, rather than hormones or tissue maturity (8, 9) . The preferential enrichment of PC16:0/16:0, PC16:0/14:0, and PC16:0/16:1 in surfactant is explained by intracellular transport mechanisms favoring PC components containing fatty acids with 14 -16 carbon (3, 13, 23) . Consequently, the processes resulting in variable PC16:0/16:0-to-PC16:0/14:0 ratios of surfactant appear to occur before surfactant assembly into lamellar bodies.
Relevance of precursors for surfactant PC synthesis. A large body of evidence suggests that PC synthesis in PN-II depends on exogenous choline for head group formation, whereas the glycerol moiety originates from circulating glucose or pulmonary glycogen stores (20, 35, 38) . Our different nutrition regimens did not change choline and phosphocholine concentrations in plasma and lungs, suggesting no role for altered choline/phosphocholine supply in the surfactant changes observed. Moreover, PN-II comprise all the enzymes to synthesize, desaturate, and elongate fatty acids (for review, see Ref. 30) , suggesting a high degree of metabolic self supply for the generation and storage of the PC species characteristic of surfactant. In utero, the 2-carbon units for C16:0 synthesis, the principle fatty acid of the main surfactant component PC16:0/ 16:0, originate from circulating glucose or from fetal pulmonary glycogen (31) . Such fatty acid synthesis is essential during fetal development, where 80% of synthesized fatty acids are found in lung phospholipids (7) . However, while the end product of endogenous fatty acid synthesis in the lungs is predominantly C16:0, fatty acid synthesis decreases shortly before term, following exhaustion of the glycogen stores (d20 -d21 in rats), whereas choline incorporation as a parameter of surfactant synthesis further increases (31) . From these findings, it must be assumed that, from end gestation onwards, exogenous supply of the lungs with fatty acid may significantly modify the surfactant PC profile, if its chain length fits into the incorporation and sorting program of PN-II.
Role of exogenous fatty acid supply for surfactant synthesis. Our laboratory previously demonstrated the dependence of PC16:/14:0 on the dietary intake of C14:0. Using C14:0 3 as the exclusive exogenous fatty acid source resulted in the generation of a surfactant where PC16:0/14:0 became the major PC species at the expense of PC16:0/16:0. The same, but less pronounced, effect was induced by C12:0 3 , although C12:0 was only incorporated into PC following lung-specific elongation to C14:0 (27) . The occurrence of the same processes under normal physiological conditions was demonstrated in these experiments, where newborn rat surfactant transiently switched from being a high-PC16:0/16:0 to a high-PC16:0/14:0, containing surfactant during postnatal milk feeding, which also coincides with alveolar formation, and where prolonged milk feeding maintains a surfactant with increased PC16:0/14:0. We found a positive correlation between C14:0 enrichment in lung tissue and surfactant PC (PC16:0/14:0), and C14:0 concentrations in plasma and lung TG. Since the lungs express lipoprotein lipase (18) , exogenous TG from very low density lipoproteins (12, 15, 25, 33, 40) , as well as from chylomicrons (see RESULTS) , are potent fatty acid sources of the lungs. Our data demonstrate that chylomicron-mediated effects play a major role in the profile changes of disaturated PC of surfactant. Importantly, they are restricted to the incorporation of C14:0 into PC, resulting in an enrichment of surfactant with PC16:0/14:0. Although milk nutrition also provides C12:0, this fatty acid was not found in PC. This is in accordance with our laboratory's previous finding that C12:0 is elongated to C14:0 before incorporation, and that any traces of C12:0 directly incorporated into lung PC are rapidly removed (27) . In essence, enrichment of C14:0 in PC is specific to mammalian lung surfactant, based on preferential accumulation of C14:0 in pulmonary lipid stores, but not in other organs like the liver, where C14:0 is readily metabolized, or in birds in which PC16:0/16:0 comprises 75% of surfactant PC and in which PC16:0/14:0 is virtually absent (2, 3, 23, 27, 29) .
Lung specificity of PC16:0/14:0 synthesis. The enrichment in C12:0 and C14:0 of lung TG correlates well with their values in plasma TG. In accordance with previous experiments, PN-II use C14:0 from lung, as well as from plasma TG (27, 39) . Also, in suckling rats, C14:0 is increased in the plasma free fatty acid fraction (34) . However, while C14:0 rapidly vanishes from plasma TG after cessation of exogenous supply, its decrease in lung TG and PC is slower, highlighting its slow pulmonary turnover. By contrast, exogenous C14:0 did not increase C14:0 in liver and plasma PC or liver TG, implying that neither PC nor TG secreted by the liver contribute to increased PC16:0/14:0 in lung surfactant of rats, although the liver may well contribute to overall surfactant homoeostasis (12) , and C14:0 metabolism may be different in humans and guinea pigs (3, 5) . However, our data not only suggest lungspecific accumulation of this fatty acid under physiological conditions, but also raise the question of the underlying physiological importance.
Function of PC16:0/14:0 in mammalian surfactant. Surface tension function of surfactant enriched in PC16:0/14:0 was not impaired, which is consistent with the finding that even "inverted" PC profiles with high PC16:0/14:0 and PC16:0/16:0 down to 2-20% are compatible with normal respiration (3, 21, 27) . On the other hand, low PC16:0/14:0 concentrations are a better indicator of lung immaturity than PC16:0/16:0 and correlate with bronchopulmonary dysplasia and lung emphysema (3, 29) . Hence, it is tempting to assume a role of PC16:0/14:0 in alveolar maintenance. This is supported by previous findings that bird lungs do not possess alveoli and that the alveolar M⌽-like cells in their lungs do not have PC16:0/ 14:0 in their surfactant (2, 24) . Furthermore, in vitro data show that PC16:0/14:0 specifically mimics several of those effects on M⌽ differentiation characteristic of natural lipid extract surfactant containing this component, like increased HLA-DR and CD80 expression, and decreased M⌽-triggered T-lymphocyte proliferation (17) . In keeping with this, we show here that, in freshly isolated alveolar M⌽, the production of ROS, another pivotal proinflammatory function of M⌽, is attenuated in rats with elevated pulmonary PC16:0/14:0 levels. ROS are generated by alveolar M⌽ upon activation and are essential for local host defense (19) , whereas uncontrolled ROS release may lead to severe tissue damage (36) . Previous age-related investigations on rat alveolar M⌽ showed that conventionally fed young rats exhibit elevated ROS production (37) . Conversely, our experiments show diminished ROS production in 14d rats fed on a C14:0-rich diet. Therefore, we speculate that an elevated PC16:0/14:0 proportion in surfactant may attenuate ROS production.
Surfactant and PC metabolism of alveolar M⌽. Comparing the PC metabolism of alveolar M⌽ after 1.5 h [D 9 -methyl]choline incorporation, when only minute amounts of newly synthesized D 9 -labeled surfactant PC have entered the alveolar space (not shown), with that of nonlabeled PC suggests that PC homeostasis of alveolar M⌽ is dictated by the lipid composition of the surrounding surfactant. If recycling of endocytosed surfactant fatty acids were to play a significant role in M⌽ PC homeostasis, one would expect higher concentrations of D 9 - choline-labeled PC16:0/14:0, PC16:0/16:0, and PC16:0/16:1 from M⌽ synthesis after 1.5 h, rather than the predominant synthesis of polyunsaturated PC. Rather, it is dictated by the presence and lipidomic composition of the surfactant-rich surrounding, which may be important for the exposure to synthetic surfactant lacking PC16:0/14:0, and the function of these cells.
However, the PC metabolism of alveolar M⌽ appears independent of surfactant fatty acid supply, although it cannot be excluded that some C14:0 released from absorbed PC16:0/14:0 is used for protein myristoylation, e.g., of the inhibitory ␣-subunit of G proteins regulating M⌽ function (10) . Instead, these cells predominantly ad-and absorb surfactant PC, as defined by their alveolar environment and the metabolic characteristics of surfactant producing PN-II. While the latter clearly depends on C14:0 nutrition and development, direct examination of the effect of diets high in C14:0 fatty acids compared with those low in C14:0 in age-matched rats (27) will be necessary to investigate in more detail the specificity of C14:0 and PC16: 0/14:0-enriched surfactant on M⌽ function for pulmonary homeostasis.
In conclusion, the concentrations of saturated PC components in surfactant, PC16:0/14:0, and PC16:0/16:0 are modified by differences in the exogenous supply of C14:0. Whereas shorter fatty acids, such as C12:0, are excluded from PC synthesis, C14:0 enrichment in PC is restricted to the lungs. In rats, this metabolic process is mediated by chylomicrons, whereas, in other mammals, transplacental secretion may contribute. Physiologically, C16:0/14:0 enrichment may be more important for alveolar M⌽ homoeostasis than for surface tension function, where the development-dependent surfactant PC metabolism influences the PC homeostasis of alveolar M⌽. Taken together, these findings strongly support further investigations into the association between PC16:0/14:0, alveolar immune-homeostasis, and pulmonary disease.
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